Linda T. Vahdat, M.D., M.B.A.
425 East 61st Street, 8th Floor
New York, NY 10065
P: (212) 821-0644 | F: (212) 821-0758
425 E. 61st St., 8-11th Floor
New York, NY 10065
P: 212-821-0644 | F: 212-821-0758
I only care for those with breast cancer. Within breast cancer my major interest is in metastatic disease or high risk adjuvant. The reason for this is that I am involved in many new therapies to treat existing breast cancer as well as strategies to reduce the risk of relapse of breast cancer that has not recurred.
Another research interest of mine is to understand and hopefully impact the development of chemotherapy induced peripheral neuropathy.
- Internal Medicine
- Medical Oncology
- Medical Oncology
- Breast Oncology
- Breast Cancer
Insurance Plans Accepted
The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please contact the physician’s office as they may have individual contracts not included on this site.
* indicates this physician is no longer accepting new patients with this insurance plan.
- AETNA [PPO]
- AETNA [Medicare]
- AETNA [HMO]
- Aetna - Weill Cornell [POS]
- Affinity Essential
- Affinity Health Plan
- Blue Priority Network
- Emblem Select Care
- Empire Blue Cross/Blue Shield [Mediblue (Senior)]
- Empire Blue Cross/Blue Shield [PPO]
- Empire Blue Cross/Blue Shield [HMO]
- Empire Blue Cross/Blue Shield [EPO]
- Empire Blue Cross/Blue Shield [Pathway X]
- Empire Blue Cross/Blue Shield [Pathway X Enhanced]
- Empire Blue Cross/Blue Shield HealthPlus
- Empire Blue Cross/Blue Shield HealthPlus [CHP]
- Fidelis Care
- GHI [CBP]
- Health First
- Health Insurance Plan of NY (HIP) [Medicare]
- Health Insurance Plan of NY (HIP) [Medicaid]
- Health Insurance Plan of NY (HIP)
- Oxford Health Plans [Medicare Advantage]
- Oxford Health Plans [Metro/Core/Charter]
- Oxford Health Plans [Freedom]
- Oxford Health Plans [Liberty]
- Rockefeller University - CoreSource
- UHC Compass
- United Empire
- United Health Care
- United Health Care [Medicare]
- United Health Care [Community Plan]
- VNSNY CHOICE [Medicare]
- VNSNY CHOICE [HMO]
- B.A., Barnard College - Columbia University, 1982
- M.D., Mount Sinai School of Medicine, 1987
Honors and Awards
1998 Outstanding Service Award from Cancer Care, Inc.
1999 Outstanding Service Award from Cancer Care, Inc.
2002 "Physician of the Year" Award from Cancer Care, Inc.
2003-2007 Outstanding Service Award from Cancer Care, Inc.
2007 Margie Filter Individual Achievement Award from Cancer Care of Connecticut, Inc.
2010 ASCO Statesman Award
2011 Scientific Research and Advancements in Breast Cancer Award
From Susan G Komen for the Cure
2011 Margery Price Annual Breast Cancer Symposium Award from Mount
Sinai School of Medicine
Professor of Medicine
Weill Cornell Medical College, Cornell University
Linda T. Vahdat, MD, MBA, is a Professor of Medicine at Weill Cornell Medical College as well as an Attending Physician at NewYork-Presbyterian Hospital in New York City. She is currently the Director of the Breast Cancer Research Program, at Weill Cornell Medicine and Co-Leader of the Breast Cancer Program within the Meyer Cancer Center. Until recently, she led the Solid Tumor Service at Weill Cornell, stepping down in 2015 to focus more on breast cancer-related activities.
Dr. Vahdat earned her undergraduate degree at Barnard College/Columbia University in New York City and completed her medical degree at Mount Sinai School of Medicine. She remained at Mount Sinai for her residency training in Internal Medicine and completed fellowship training in Medical Oncology and Hematology at the Memorial Sloan-Kettering Cancer Center (MSKCC). In 2014, Dr. Vahdat completed a master’s degree in business administration (MBA) at the Sloan School of Management at the Massachusetts Institute of Technology. She found it to be a perfect complement to her research activities since the program focused on management, operations, entrepreneurship and data analytics.
Although a translational breast cancer medical oncologist by training, Dr. Vahdat’s expertise is in drug development. She has been involved in the identification, conceptualization, design and execution of Phase 0 through III clinical trials of new therapies in high-risk adjuvant and metastatic breast cancer patients since 1994. She has led two separate drug development efforts that led to the FDA approval of two leading drugs to fight metastatic breast cancer, and her team has taken the lead for at least two other drugs that have a high probability of success, both in triple negative breast cancer. In 2014, she founded the Triple Negative Breast Cancer Clinic -- one of only two dedicated clinics in the U.S. Dr. Vahdat’s other significant research interests include preventing breast cancer metastases and minimizing side effects of treatment, including chemotherapy-induced peripheral neuropathy. She is motivated to integrate new technology into translational medicine and has a number of collaborations both at Cornell Biogengineering and at MIT that she hopes will change how we view and treat cancer. She has also been actively involved and has held several leadership positions in the American Society of Clinical Oncology (ASCO), including Co-Chair of ASCO Breast Cancer Symposium. Dr. Vahdat also served on the Executive Board of Cancer Care from 2006 until 2012.